Respiratory syncytial virus infection enhances pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 6, 2016, Pages 1642-1647

  Hendricks, Matthew R ^a   Lashua, Lauren P ^a   Fischer, Douglas K ^a   Flitter, Becca A ^a   Eichinger, Katherine M ^b   Durbin, Joan E ^c   Sarkar, Saumendra N ^a,d   Coyne, Carolyn B ^a   Empey, Kerry M ^b   Bomberger, Jennifer M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Biofilm; Cystic Fibrosis; Nutritional Immunity; Pseudomonas Aeruginosa; Respiratory Syncytial Virus

Indexed keywords

FERRITIN; GAMMA INTERFERON; IRON; IRON BINDING PROTEIN; LACTATE DEHYDROGENASE; LACTOFERRIN; TRANSFERRIN; ANTIVIRUS AGENT; BETA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; ELECTRIC RESISTANCE; HOMEOSTASIS; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; HUMAN RHINOVIRUS B14; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MIXED INFECTION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; ANIMAL; BIOLOGICAL MODEL; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHUS; CYSTIC FIBROSIS; DRUG EFFECTS; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNITY; METABOLISM; MICROBIOLOGY; NUTRITION; ORGANISMAL INTERACTION; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; BIOFILMS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; IMMUNITY; INTERFERON-BETA; IRON; MICE; MICROBIAL INTERACTIONS; MODELS, BIOLOGICAL; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; TRANSFERRIN;

EID: 84957806130     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1516979113     Document Type: Article

References (49)

1. Tang AC, et al. (2014) Current concepts: Host-pathogen interactions in cystic fibrosis airways disease. Eur Respir Rev 23(133):320-332.
2. Suárez-Arrabal MC, et al. (2015) Nasopharyngeal bacterial burden and antibiotics: Influence on inflammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis. J Infect 71(4):458-469.
3. Varkey JB, Varkey B (2008) Viral infections in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med 14(2):89-94.
4. van Ewijk BE, van der Zalm MM, Wolfs TF, van der Ent CK (2005) Viral respiratory infections in cystic fibrosis. J Cyst Fibros 4(Suppl 2):31-36.
5. Wat D, et al. (2008) The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 7(4):320-328.
6. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP (1995) Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 73(2):117-120.
7. Collinson J, et al. (1996) Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 51(11):1115-1122.
8. Hiatt PW, et al. (1999) Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 103(3):619-626.
9. Brownlee JW, Turner RB (2008) New developments in the epidemiology and clinical spectrum of rhinovirus infections. Curr Opin Pediatr 20(1):67-71.
10. Petersen NT, et al. (1981) Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma-possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 70(5):623-628.
11. Costerton JW (2001) Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 9(2):50-52.
12. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: A common cause of persistent infections. Science 284(5418):1318-1322.
13. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T (2010) An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 59(3):253-268.
14. Cassat JE, Skaar EP (2013) Iron in infection and immunity. Cell Host Microbe 13(5):509-519.
15. Reid DW, Lam QT, Schneider H, Walters EH (2004) Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur Respir J 24(2):286-291.
16. Gifford AH, et al. (2012) Iron homeostasis during cystic fibrosis pulmonary exacerbation. Clin Transl Sci 5(4):368-373.
17. Hunter RC, et al. (2013) Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. MBio 4(4):e00557-13.
18. Moreau-Marquis S, et al. (2008) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol 295(1):L25-L37.
19. Zemke AC, et al. (2014) Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells. Free Radic Biol Med 77:307-316.
20. O'Toole GA, Kolter R (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: A genetic analysis. Mol Microbiol 28(3):449-461.
21. Van Ewijk BE, et al. (2007) RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 61(4):398-403.
22. Mordstein M, et al. (2010) Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84(11):5670-5677.
23. Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417(6888):552-555.
24. Banin E, Vasil ML, Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci USA 102(31):11076-11081.
25. Mickelsen PA, Sparling PF (1981) Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect Immun 33(2):555-564.
26. Herrington DA, Sparling PF (1985) Haemophilus influenzae can use human transferrin as a sole source for required iron. Infect Immun 48(1):248-251.
27. Senkovich O, Ceaser S, McGee DJ, Testerman TL (2010) Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media. Infect Immun 78(5):1841-1849.
28. Empey KM, et al. (2012) Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PLoS One 7(7):e40499.
29. Johansen HK, Høiby N (1992) Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47(2):109-111.
30. Chattoraj SS, et al. (2011) Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells. Infect Immun 79(10):4131-4145.
31. Bomberger JM, et al. (2014) Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation. J Biol Chem 289(1):152-162.
32. Hament JM, et al. (2004) Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus. Pediatr Res 55(6):972-978.
33. Durbin RK, Kotenko SV, Durbin JE (2013) Interferon induction and function at the mucosal surface. Immunol Rev 255(1):25-39.
34. Nakamura S, Davis KM, Weiser JN (2011) Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest 121(9):3657-3665.
35. Kudva A, et al. (2011) Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 186(3):1666-1674.
36. Shahangian A, et al. (2009) Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119(7):1910-1920.
37. Cohen TS, Prince AS (2013) Bacterial pathogens activate a common inflammatory pathway through IFNλ regulation of PDCD4. PLoS Pathog 9(10):e1003682.
38. Patriquin GM, et al. (2008) Influence of quorum sensing and iron on twitching motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol 190(2):662-671.
39. Reid DW, Carroll V, O'May C, Champion A, Kirov SM (2007) Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur Respir J 30(2):286-292.
40. Moreau-Marquis S, O'Toole GA, Stanton BA (2009) Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol 41(3):305-313.
41. Chua SL, et al. (2014) Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles. Nat Commun 5:4462.
42. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK (2007) The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 117(4):877-888.
43. Banin E, et al. (2008) The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci USA 105(43):16761-16766.
44. Sriyosachati S, Cox CD (1986) Siderophore-mediated iron acquisition from transferrin by Pseudomonas aeruginosa. Infect Immun 52(3):885-891.
45. Martin LW, Reid DW, Sharples KJ, Lamont IL (2011) Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24(6):1059-1067.
46. Marvig RL, et al. (2014) Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. MBio 5(3):e00966-e14.
47. Nguyen AT, et al. (2014) Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung. J Bacteriol 196(12):2265-2276.
48. Committee on Care and Use of Laboratory Animals (1996) Guide for the Care and Use of Laboratory Animals (Natl Inst Health, Bethesda), DHHS Publ No (NIH) 85-23, pp 1-13.
49. Bomberger JM, et al. (2011) A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog 7(3):e1001325.